Real-world clinical outcomes and economic burden of early discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer

被引：0
|
作者：
Patel, Jeetvan
Nguyen, Jennifer
Bollu, Vamsi
Kang, Barinder
Sawhney, Amrita
Byrne, Clare
Tang, Jackson
Gorritz, Magdaliz
Chen, Chi-Chang
Shore, Neal D.
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] Asclepius Analyt, New York, NY USA
[3] IQVIA Inc, King Of Prussia, PA USA
[4] Carolina Urol Res Ctr, Myrtle Beach, SC USA
[5] GenesisCare US, Myrtle Beach, SC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17043
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Exposure–response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer
    M. van Nuland
    S. L. Groenland
    A. M. Bergman
    N. Steeghs
    H. Rosing
    N. Venekamp
    A. D. R. Huitema
    J. H. Beijnen
    Prostate Cancer and Prostatic Diseases, 2020, 23 : 244 - 251
  • [42] Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer
    Shore, Neal
    Higano, Celestia S.
    George, Daniel J.
    Sternberg, Cora N.
    Saad, Fred
    Tombal, Bertrand
    Miller, Kurt
    Kalinovsky, Jan
    Jiao, XiaoLong
    Tangirala, Krishna
    Sartor, Oliver
    PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (04) : 680 - 688
  • [43] Real-world treatment (Tx) patterns of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the US
    Shore, N.
    Laliberte, F.
    Ionescu-Ittu, R.
    Gayle, A.
    Amin, S.
    Yang, L.
    Payne, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S534 - S535
  • [44] Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer
    Neal Shore
    Celestia S. Higano
    Daniel J. George
    Cora N. Sternberg
    Fred Saad
    Bertrand Tombal
    Kurt Miller
    Jan Kalinovsky
    XiaoLong Jiao
    Krishna Tangirala
    Oliver Sartor
    Prostate Cancer and Prostatic Diseases, 2020, 23 : 680 - 688
  • [45] Real-world treatment patterns in French metastatic castration-resistant prostate cancer patients under abiraterone or enzalutamide
    Scailteux, L. M.
    Vincendeau, S.
    Gravis, G.
    Mathieu, R.
    Balusson, F.
    Kerbrat, S.
    Oger, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 10 - 11
  • [46] Real-world data on the comprehensive genetic profiling test for Japanese patients with metastatic castration-resistant prostate cancer
    Koguchi, Dai
    Tsumura, Hideyasu
    Tabata, Ken-ichi
    Shimura, Soichiro
    Satoh, Takefumi
    Ikeda, Masaomi
    Watanabe, Akinori
    Yoshida, Tsutomu
    Sasaki, Jiichiro
    Matsumoto, Kazumasa
    Iwamura, Masatsugu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (05) : 569 - 576
  • [47] Real-world data on metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: A regional experience
    Raju, R.
    Sahu, A.
    Klevansky, M.
    Torres, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S1332 - S1332
  • [48] REAL-WORLD EFFECTIVENESS AND TREATMENT ADHERENCE OF APALUTAMIDE IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS
    Lowentritt, Benjamin
    Brown, Gordon
    Kernen, Kenneth
    Pilon, Dominic
    Ellis, Lorie
    Germain, Guillaume
    Rossi, Carmine
    Lefebvre, Patrick
    Sieber, Paul
    Shore, Neal
    JOURNAL OF UROLOGY, 2021, 206 : E58 - E58
  • [49] Real-world outcomes in patients with metastatic castration-resistant prostate cancer beyond progression after upfront androgen receptor signaling inhibitor
    Yamamoto, Yutaka
    Fujimoto, Saizo
    Hashimoto, Mamoru
    Minami, Takafumi
    Fukuokaya, Wataru
    Yanagisawa, Takafumi
    Saruta, Masanobu
    Takahara, Kiyoshi
    Nishimura, Kazuki
    Tsujino, Takuya
    Nakamori, Yuta
    Hashimoto, Takeshi
    Kimura, Takahiro
    Shiroki, Ryoichi
    Azuma, Haruhito
    Ohno, Yoshio
    Fujita, Kazutoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, : 1946 - 1958
  • [50] Clinical characteristics and outcomes for patients with non-metastatic castration-resistant prostate cancer
    Arnold, Peter
    Penaloza-Ramos, Maria Cristina
    Adedokun, Lola
    Rees, Sarah
    Lockhat, Mohamed
    Spary, Lisa
    Watkins, Alan
    Gnanapragasam, Vincent
    Crabb, Simon J.
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345